Singapore - English - HSA (Health Sciences Authority)

novem pharma private limited - eplerenone - tablet, film coated - eplerenone 50.000 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - eplerenone, quantity: 50 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; croscarmellose sodium; hypromellose; sodium lauryl sulfate; purified talc; magnesium stearate; titanium dioxide; polysorbate 80; iron oxide yellow; iron oxide red; macrogol 400 - inspra is indicated: to reduce the risk of cardiovascular death in combination with standard therapy in patients who have evidence of heart failure and left ventricular impairment within 3-14 days of an acute myocardial infarction (see clinical trials and dosage and administration). to reduce the risk of cardiovascular mortality and morbidity in adult patients with nyha class ii (chronic) heart failure and left ventricular systolic dysfunction (lvef less than or equal to 30% or lvef less than or equal to 35% in addition to qrs duration of greater than 130 msec), in addition to standard optimal therapy (see clinical trials).

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - eplerenone, quantity: 25 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; croscarmellose sodium; hypromellose; sodium lauryl sulfate; purified talc; magnesium stearate; titanium dioxide; polysorbate 80; iron oxide yellow; iron oxide red; macrogol 400 - inspra is indicated: to reduce the risk of cardiovascular death in combination with standard therapy in patients who have evidence of heart failure and left ventricular impairment within 3-14 days of an acute myocardial infarction (see clinical trials and dosage and administration). to reduce the risk of cardiovascular mortality and morbidity in adult patients with nyha class ii (chronic) heart failure and left ventricular systolic dysfunction (lvef less than or equal to 30% or lvef less than or equal to 35% in addition to qrs duration of greater than 130 msec), in addition to standard optimal therapy (see clinical trials).

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - spironolactone - film-coated tablet - 25 milligram(s) - aldosterone antagonists; spironolactone

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - spironolactone - film-coated tablet - 50 milligram(s) - aldosterone antagonists; spironolactone

Ireland - English - HPRA (Health Products Regulatory Authority)

primecrown 2010 limited - spironolactone - film-coated tablet - 25 milligram(s) - aldosterone antagonists; spironolactone

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - spironolactone - film-coated tablet - 100 milligram(s) - aldosterone antagonists; spironolactone

Ireland - English - HPRA (Health Products Regulatory Authority)

imbat limited - spironolactone - film-coated tablet - 25 milligram(s) - aldosterone antagonists; spironolactone

Ireland - English - HPRA (Health Products Regulatory Authority)

les laboratoires servier - perindopril arginine; indapamide; amlodipine - film-coated tablet - 5 mg/1.25 mg/10 milligram(s) - ace inhibitors, other combinations; perindopril, amlodipine and indapamide

Ireland - English - HPRA (Health Products Regulatory Authority)

les laboratoires servier - perindopril arginine; indapamide; amlodipine - film-coated tablet - 10 mg/2.5 mg/5 milligram(s) - ace inhibitors, other combinations; perindopril, amlodipine and indapamide